Objectives: The volume of pleural effusion is one of the determinants of chest drain removal following pulmonary resection. Recent research suggests that values up to 400 ml/day are safe. The objective of this study was to develop an aggregate risk score to identify patients at higher risk of developing a large pleural effusion (LPE) (>400 ml/day) on postoperative day 2 (POD2) after pulmonary lobectomy.
Methods: An observational study on 229 consecutive patients was conducted prospectively in two European centres (June 2012-September 2013). All patients underwent pulmonary lobectomy for lung cancer (thoracotomy: 131, video-assisted thoracic surgery: 98) and managed by single chest tube connected to an electronic-regulated suction device. Exclusion criteria were chest wall or diaphragm resection and postoperative-assisted mechanical ventilation. To build the aggregate score, variables were initially screened by univariable analysis, and then used in stepwise logistic regression analysis (validated by bootstrap). The scoring system was developed by proportional weighing of the significant predictor estimates, and patients were grouped in classes of incremental risk according to their total score.
Results: The incidence of LPE on POD2 was 23% (53 of 229 patients). The independent risk factors associated with LPE on POD2 were age greater than 70 years (P = 0.01, bootstrap frequency 71%), a lower lobectomy (P = 0.03, bootstrap frequency 59%) and presence of COPD (P = 0.02, bootstrap frequency 63%). Each predictor received a weighted score of 1, and patients were grouped into three risk classes showing an incremental risk of LPE (P < 0.001): Class A (Score 0) 5 LPE in 66 patients, 7.5%; Class B (Score 1) 19 LPE in 88 patients, 22%; Class C (Score >1) 29 LPE in 75 patients, 39%.
Conclusions: The aggregate score is a reliable tool for identifying high-risk patients for LPE and assists in the selection of patients that can safely proceed to chest drain removal early after surgery.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1093/ejcts/ezu413 | DOI Listing |
Eur J Trauma Emerg Surg
January 2025
Emergency Department, Tel Aviv Sourasky Medical Center, 6 Weizman Street, 6423906, Tel Aviv, Israel.
Objective: To evaluate the NEXUS Chest CT ALL decision instrument (DI) in reducing unnecessary chest CT imaging in minor blunt trauma patients while preserving high sensitivity for detecting clinically meaningful injuries. Additionally, we examined the impact of delayed presentation, chronic disease, and anticoagulation/anti-aggregation medications on trauma outcomes.
Methods: This retrospective study included 853 adult minor blunt trauma patients who underwent chest CT in the emergency department (ED) of Tel-Aviv Sourasky Medical Center between 2018 and 2022.
Clin Transl Sci
February 2025
The Cardiovascular Department, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
Coronary artery disease remains a significant global health issue and is a leading cause of mortality. Dual antiplatelet therapy, including clopidogrel, is essential for preventing stent thrombosis after coronary artery stenting. This study assessed the comparative efficacy and safety of generic versus brand-name clopidogrel in a large Taiwanese cohort.
View Article and Find Full Text PDFGenetic prediction of complex traits, enabled by large-scale genomic studies, has created new measures to understand individual genetic predisposition. Polygenic Risk Scores (PRS) offer a way to aggregate information across the genome, enabling personalized risk prediction for complex traits and diseases. However, conventional PRS calculation methods that rely on linear models are limited in their ability to capture complex patterns and interaction effects in high-dimensional genomic data.
View Article and Find Full Text PDFCo-existing neuropathological comorbidities have been repeatedly reported to be extremely common in subjects dying with dementia due to Alzheimer disease. As these are likely to be additive to cognitive impairment, and may not be affected by molecularly-specific AD therapeutics, they may cause significant inter-individual response heterogeneity amongst subjects in AD clinical trials. Furthermore, while originally noted for the oldest old, recent reports have now documented high neuropathological comorbidity prevalences in younger old AD subjects, who are more likely to be included in clinical trials.
View Article and Find Full Text PDFNeural Netw
January 2025
School of Computer Science and Technology, Huazhong University of Science and Technology, Wuhan, 430070, Hubei, China.
In the Imbalanced Multivariate Time Series Classification (ImMTSC) task, minority-class instances typically correspond to critical events, such as system faults in power grids or abnormal health occurrences in medical monitoring. Despite being rare and random, these events are highly significant. The dynamic spatial-temporal relationships between minority-class instances and other instances make them more prone to interference from neighboring instances during classification.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!